3645 results for «695»

Filter By

3645 results

PCR Gulf Valves 2025 Closing Ceremony

30 Sep 2025 – From PCR Gulf Valves 2025

Join the PCR Gulf Valves 2025 Closing Ceremony to reflect on the advancements and highlights of this year’s sessions dedicated to valvular interventions. This event marks the culmination of comprehensive educational activities, fostering collaboration and innovation in valvular heart disease management within the Gulf region.

PCR Gulf Valves 2025 Closing Ceremony

PCR Gulf Valves 2025 Opening Ceremony

29 Sep 2025 – From PCR Gulf Valves 2025

Join us for the PCR Gulf Valves 2025 Opening Ceremony, marking the commencement of an exceptional congress dedicated to advances in structural heart interventions. This session sets the stage for the latest innovations and expert discussions that will shape the future of valve therapies in the...

PCR Gulf Valves 2025 Opening Ceremony

Tricuspid transcatheter therapies: the game changer

29 Sep 2025 – From PCR Gulf Valves 2025

Explore the evolving landscape of tricuspid transcatheter therapies in this comprehensive session reviewing tricuspid regurgitation etiology, anatomy, and current treatment options. Learn about various transcatheter tricuspid valve intervention devices, their strengths and limitations, and the critical diagnostic and intraprocedural imaging requirements to optimize patient selection and...

Tricuspid transcatheter therapies: the game changer

Mitral valve-in-valves: echocardiography and CT scan

29 Sep 2025 – From PCR Gulf Valves 2025

This session provides in-depth knowledge on imaging planning for mitral valve-in-valve procedures, focusing on echocardiography and CT scan assessment. Learn the critical role of intraprocedural imaging guidance to ensure procedural success and patient safety during mitral valve-in-valve interventions.

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device

16 May 2024

Coronary obstruction is a major concern in patients undergoing TAVI for degenerated bioprostheses (valve-in-valve [ViV]) and is associated with a 30-day mortality rate of around 50%.1 While several transcatheter techniques to lacerate bioprosthetic valve leaflets prior to TAVI placement (such as BASILICA) have been described, they are...

Pivotal study on the ShortCut transcatheter aortic valve leaflet splitting device
Didn’t find what you were looking for?